Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.
Arcuri LJ, Nabhan SK, Cunha R, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Atta EH, de Oliveira JSR, Funke VAM, Loth G, Junior LGD, Paz A, Calixto RF, Gomes AA, Araujo CES, Colturato V, Simoes BP, Hamerschlak N, Flowers ME, Pasquini R, Rocha V, Bonfim C. Arcuri LJ, et al. Among authors: de oliveira jsr. Biol Blood Marrow Transplant. 2020 Dec;26(12):2311-2317. doi: 10.1016/j.bbmt.2020.09.007. Epub 2020 Sep 17. Biol Blood Marrow Transplant. 2020. PMID: 32949751 Free article.
[Lymphoma/leukemia of T cells in adults].
Borducchi DM, Kerbauy J, de Oliveira JS. Borducchi DM, et al. Rev Assoc Med Bras (1992). 1999 Jan-Mar;45(1):63-70. doi: 10.1590/s0104-42301999000100012. Rev Assoc Med Bras (1992). 1999. PMID: 10436596 Review. Portuguese. No abstract available.
Prognosis related to staging systems for chronic lymphocytic leukemia.
de Faria JR, de Oliveira JS, Delbone de Faria RM, Silva MR, Goihman S, Yamamoto M, Kerbauy J. de Faria JR, et al. Sao Paulo Med J. 2000 Jul 6;118(4):83-8. doi: 10.1590/s1516-31802000000400002. Sao Paulo Med J. 2000. PMID: 10887382 Free PMC article.
Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial.
Cortes JE, De Souza CA, Ayala M, Lopez JL, Bullorsky E, Shah S, Huang X, Babu KG, Abdulkadyrov K, de Oliveira JSR, Shen ZX, Sacha T, Bendit I, Liang Z, Owugah T, Szczudlo T, Khanna S, Fellague-Chebra R, le Coutre PD. Cortes JE, et al. Among authors: de oliveira jsr. Lancet Haematol. 2016 Dec;3(12):e581-e591. doi: 10.1016/S2352-3026(16)30167-3. Lancet Haematol. 2016. PMID: 27890073 Clinical Trial.
19 results